The future of cryopreservation with ultra rapid vitrification
ESHRE Webinar
organised by the ESHRE Special Interest Group Embryology
Type
Advanced
Learning objectives
Participants will have the opportunity to learn about the new vitrification protocols and their success rates.
Course description
Over the years, vitrification has become the preferred method for cryopreserving oocytes and embryos. Recently, protocols with shorter vitrification times have emerged, but are the success rates comparable?, Are our laboratories ready to adopt these protocols?, What changes would this bring? are all questions that will be explored during this webinar, shedding light on the potential implications of adopting these new protocols.
Target audience
Embryologists, ART technicians, researchers, clinicians and other personnel involved in reproductive medicine and ART
Needs assessment
Studies have been published using different vitrification and devitrification protocols. Given that this is one of the most commonly used techniques in laboratories, it is essential for participants to understand these changes, assess whether the success rates are comparable and stay informed about the latest advancements in cryopreservation.
Expected educational outcomes
Participants will gain comprehensive insights into the latest advancements in vitrification, including updates on protocols, success rates and their potential impact on laboratory practices.
Programme
Please take the time zone differences into account. Times are shown in Central European Time (CEST)
13:00 - 13:05
|
Introduction by Stefano Canosa (Italy)
|
13:05 - 13:45
|
Presentation by Juergen Liebermann (USA)
|
13:45 - 14:00 |
Q&A by Stefano Canosa (Italy)
|
Practicalities
Participants will receive an e-mail with instructions on how to access the webinar (Zoom). Participants can obtain a certificate of attendance after watching the webinar on the eCampus platform. The recording will become available on the eCampus platform after the webinar took place. There will only be 500 places available to follow live.